hastened recovery and prevented the need for Background -Rates of fresh gas flow intubation and mechanical ventilation. 1 In a (FGF) commonly used when continuous group of patients with dynamic hyperinflation positive airway pressure (CPAP) is de-and intrinsic positive end expiratory pressure livered by face mask theoretically reduce (PEEP) Petrof and co-workers 2 found that the the delivery and availability of therapeutic application of CPAP to intubated patients sigaerosols. As it may be hazardous for nificantly reduced respiratory work. It seems patients with acute respiratory failure to likely that non-invasive CPAP will produce a interrupt mask CPAP, the effects of CPAP similar benefit in patients with acute severe on aerosol kinetics and bronchodilator asthma or acute exacerbations of chronic airefficacy were investigated. flow obstruction. However, therapeutic aeroMethod -The effect of CPAP at 10 cm H 2 O sols are central to the management of these at a FGF rate of 50 l/min on the delivery patients, and the concurrent administration of of technetium labelled aerosol generated CPAP may interfere with drug delivery to the from a readily available jet nebuliser was distal airway. measured using a bench model of sponMask CPAP is optimally applied through a taneous respiration. In a separate clinical continuous fresh gas flow (FGF) circuit as this study the bronchodilator responses to in-imposes less additional work than a demand cremental doses of nebulised salbutamol valve system 3 4 and compensates more effiwere measured in nine stable asthmatic ciently for potential gas leaks around the mask. subjects in a random sequence of con-Despite the use of a six litre compressed resventional nebulisation (control) or ne-ervoir bag, we found that an FGF rate apbulisation whilst receiving CPAP via a proaching the patient's peak inspiratory flow tight fitting face mask. Each patient acted rate is needed to minimise the additional work as his or her own control.
mediately proximal to the mask and the FGF and nebuliser driving gases were compressed wall gas with no external humidification.
During CPAP conditions a disposable hydrophobic filter (Pall, , Portsmouth, UK) was used as an absolute aerosol trap 16 and placed immediately distal to the face mask (F 1 , fig 1) . Activity deposited on this filter was measured as an estimate of the proportion of aerosol available for respiration by the simulated patient and was expressed as a percentage of the initial nebuliser charge (inhaled aerosol %). A second filter (F 2 activity was measured by counts taken after nebulisation was complete. Aerosol impaction in the mask and CPAP valve was estimated by subtraction of the inhaled aerosol activity and Methods    residual activity from the initial nebuliser charge and expressed as its percentage (apSpontaneous breathing was simulated using a bench model of inspiration consisting of two paratus aerosol %). During control conditions of unassisted spontaneous ventilation filters compartments connected by a bar (fig 1) .
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When compartment A (simulating the res-were placed at the face mask as before and at the non-patient end of the nebuliser. Gas piratory muscles) was mechanically ventilated, compartment B (simulating the lungs) was dis-temperature was measured at the face mask with a K-type thermocouple and a digital therplaced. This model was driven by a ventilator (7200a, Puritan-Bennett, Carlsbad, California, mometer (model 52, Fluke Instruments, Illinois, USA). Gamma activity was measured by USA) providing a tidal volume of 500 ml and an inspiratory to expiratory time ratio of 1:2 a Searle Radiographics radioisotope calibrator (model CRC-22NB) and a Berthoid radiation while inspiratory flow rate and frequency were varied to produce minute volumes of 2.5, 5.0, monitor (model CB 1210D). 7.5, 10.0, and 15.0 l/min or while minute volume was kept constant at 10 l/min and tidal volume was varied at 250, 500, and 1000 ml.   Subjects An approximately 90% square flow pattern was used because it is typical of critically ill Ten subjects with chronic stable asthma and a previously demonstrated increase in forced patients.
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The compartment simulating the lungs was expiratory volume in one second (FEV 1 ) of at least 15% after nebulised 2 agonist were then connected in turn via a standard right angled connector to a face mask (Vital Signs, studied. All subjects gave written informed consent prior to commencing the investigation and Totowa, New Jersey, USA) strapped onto a tight fitting board and orifice, and to a modified the studies were approved by the hospital's Committee on Clinical Investigation. Mapleson-A CPAP circuit 5 (representing the circuit and mask applied to the face). Briefly, this consists of corrugated tubing (1.5 metres long and 19 mm internal diameter) and a six Study design Subjects were studied in a predetermined ranlitre reservoir bag (Warne Franklin, High Wycombe, Buckinghamshire, UK) compressed domised sequence of CPAP and control on two successive days at the same time of day. Inhaled by a weighted hinged board, driven by FGF at a rate of 50 l/min. This rate of gas flow was 2 agonist was withheld for at least six hours prior to each study period and the morning chosen as it is in the mid range of inspiratory flow rates of patients treated with mask CPAP dose of oral theophylline (three subjects) was not given until after each study period. Inhaled in our intensive care unit. For the CPAP experiments a 10 cm H 2 O valve (Vital Signs) was and oral corticosteroid therapy was continued unchanged. applied to the mask, and for the control experiments the mask was open to room air (that On arrival subjects rested for 10 minutes before measurement of their FEV 1 with a is, no CPAP circuit was attached).
At each pattern of ventilation the deposition Vitalograph spirometer. On the day CPAP was given the subject next received face mask CPAP of radioaerosol was determined four times under both CPAP and control conditions. In at 10 cm H 2 O using a 50 l/min FGF and the FEV 1 was again measured. Subjects then reeach experiment a nebuliser (Bird Micronebuliser P/No. 158, Bird, California, USA) ceived nebulised salbutamol (salbutamol 5% aqueous solution, Allen and Hanburys, Vicwas filled with a measured activity (approximately 50 Ci) of technetium per-toria, Australia) concurrently with CPAP in incremental doses of 250 g, 250 g, 500 g, technetate in 3 ml physiological saline (nebuliser charge) and nebulised to its residual and 1000 g at 30 minute intervals to produce a sequential doubling in cumulative dose (total volume using an input flow of 6 l/min. In each experiment the nebuliser was placed im-cumulative dose 2000 g). 17 Each dose was . control day salbutamol was administered through the same face mask and nebuliser but without the CPAP valve or FGF attached. All   measurements of FEV 1 were taken as the best Patient characteristics of three maximum forced exhalations ±0.05 Of the 10 subjects studied, one was excluded litres and were recorded with the face mask because of a fall in FEV 1 of 60% with serial and CPAP circuit removed. maximal expiratory spirometry (this met a predetermined withdrawal criterion). The remaining nine subjects (five men) of mean age   45 years (range 27-69) completed both days Radioisotope aerosol deposition was analysed of the study. Eight subjects received inhaled using the Student's t test for paired data. The budesonide (mean dose 3 mg per day; range analysis of dose and FEV 1 relationships used 1.6-3.6 mg), and one received oral predrepeated measures ANOVA. All numerical val-nisolone (10 mg/day). All drug doses had been ues are expressed as mean (SD) unless other-stable for four weeks before the study period. wise stated, and gas volumes are expressed on Four subjects received salbutamol through the the ATPS scale.
CPAP circuit on day 1.
Results

  Aerosol deposition
At a constant minute volume of 10 l/min inhaled aerosol % was independent of tidal volume and averaged for statistical comparison (fig 2) . CPAP was associated with a reduction in inhaled aerosol % from 6.85 (1.52)% under control conditions to 1.3 (0.37)% on CPAP (p<0.01). Correspondingly, the rate of FGF when on CPAP was associated with an increase in apparatus aerosol % from 13.9 (8.2)% under control conditions to 40.1 (7.6)% on CPAP.
As minute ventilation increased (tidal volume constant at 500 ml), inhaled aerosol % increased to a maximum at approximately 10 l/ min. This effect was not seen during CPAP (fig 3) . rapidly during concurrent nebulisation with group.bmj.com on June 24, 2017 -Published by http://thorax.bmj.com/ Downloaded from haled aerosol % and the fall in gas temperature found in our bench studies will favour reduced bronchodilator efficacy.
In a cohort of stable asthmatic subjects the bronchodilator response to nebulised salbutamol was not affected when the aerosol was administered via a CPAP circuit and tight fitting face mask. Caution must be exercised in extrapolating our data to critically ill patients with acute respiratory failure. In contrast to stable asthmatic subjects, patients with acute respiratory failure are likely to have higher inspiratory flow rates and smaller tidal volumes, 14 and it is known that this ventilatory pattern is associated with reduced bronchodilator aerosol delivery to the peripheral airways.
18 However, it is important to recognise that these con- may favour bronchodilator aerosol delivery to the peripheral airways by reducing both the degree of tachypnoea and inspiratory flow rate.
Baseline spirometric values
In the cohort of stable asthmatic subjects There was no difference in prebronchodilator progressive submaximal responses were seen FEV 1 on the CPAP (2.3 (0.8) l) or control to incremental doses of salbutamol, and the (2.3 (0.9) l) days of the study. The interval resultant dose-response curves were identical between the subject's last dose of salbutamol for both CPAP and control conditions. Thus, and the commencement of the study period during stable asthma, delivery of 2 agonist to was the same on each day (CPAP day, 7.9 (4.6) its parent receptor was not altered by CPAP. hours; control, 8.2 (4.4) hours). There was no For these reasons we believe it is appropriate difference in FEV 1 before (2.3 (0.8) l) and after to extend these findings to patients with airflow (2.3 (0.7) l) the application of CPAP alone obstruction during acute respiratory failure and without bronchodilator.
it is now our practice to administer 2 agonist concurrently with CPAP in these patients. We used non-humidified compressed gas in both Bronchodilator responses the clinical and bench experiments to maximise The dose-response curves for salbutamol are the temperature and osmolar changes that shown in fig 5. A log linear relationship was occur when the aerosol is entrained into the seen between cumulative dose and increase in fresh gas flow. Furthermore, as it is our ex-FEV 1 above baseline. The magnitude of the perience that many acutely breathless patients increase and the slope of the curves were ident-are unable to tolerate heating and huical for CPAP (0.0049 (0.0031)) and control midification of the circuit because of a sensation (0.0060 (0.0034)) conditions (p=0.46). The of suffocation, we do not humidify the circuit mean difference in slope between control and during the short term (less than four hours) CPAP conditions was 0.0012 (0.0047) with administration of CPAP. 95% confidence intervals of −0.0047 to Our data suggest that continuous gas flow 0.0024. The maximum increase in FEV 1 with CPAP delivered by face mask reduces total a cumulative dose of 2.0 mg was 23.7 (12.8)% aerosol delivery without affecting the bronchoduring concurrent administration with CPAP dilator efficacy of nebulised 2 agonists. The and 26.1 (16.5)% during control conditions, application of CPAP to both normal subjects 19 with a mean difference of −2.4 (13.4)% (p= and subjects with induced asthma 6 increases 0.74) and 95% confidence intervals of −12.7 minute ventilation by around 50%. We did not to 8.0. measure minute ventilation during the clinical study, but used a bench model of spontaneous respiration to allow accurate reproducible Discussion breathing patterns as minute volume was varied In a bench model of spontaneous respiration between 2.5 and 15 l/min. These values were this study has shown that CPAP induced sigchosen to include the likely range of minute nificant changes in aerosol characteristics. Inventilation in critically ill patients. From an haled aerosol % was reduced fivefold during examination of the effect of increasing minute CPAP and became independent of minute volume on aerosol delivery during CPAP (fig ventilation. These findings suggest that con-3), the consequent increase in drug reaching ditions unique to FGF mask CPAP are more the proximal airway as minute ventilation is important than minute ventilation and resincreased is far too small to explain the appiratory pattern as determinants of total inhaled parently paradoxical finding of a similar aerosol. In addition, CPAP was associated with bronchodilator response to salbutamol during a greater fall in aerosol and gas temperature during nebulisation. Both the reduction in in-its concurrent administration with CPAP.
group.bmj.com on June 24, 2017 -Published by http://thorax.bmj.com/ Downloaded from In subjects with induced asthma CPAP is and studies specific to this agent are required.
The precise mechanism by which the bronchoassociated with an increase in end expiratory dilator response to nebulised 2 agonist is mainlung volume. However, this effect is small and tained despite a significant reduction in total diminishes after several breaths.
6 While inaerosol availability also warrants further increases in lung volume may alter aerosol devestigation. livery because of alterations in airway geometry, this effect is likely to be small.
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is known to be a major determinant of aerosol Crit Care Med 1991; 19:226-70. will occur with a non-humidified fresh gas flow, 
